Ole Audun Werner Haabeth

Employment

• Nutcracker Therapeutics Senior Director, Head of target Biology
  2022 - Present
• Nutcracker Therapeutics Director
  2021 - 2022
• Stanford Medicine Instructor
  2020 - 2021
• Nutcracker Therapeutics Scientific Program manager
  2020 - 2021
• Stanford University Postdoctoral Student
  2016 - 2019

Education

• Universitetet i Oslo Det medisinske fakultet Ph.D.
  2010 - 2013
• University of Oslo Master of Science
  2007 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (43)

• Data from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.c.6509771
  +Save
• Data from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.c.6509771.v1
  +Save
• Supplementary figure S4 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417187
  +Save
• Supplementary figure S4 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417187.v1
  +Save
• Supplementary figure S3 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417193.v1
  +Save
• Supplementary figure S3 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417193
  +Save
• Supplementary figure S2 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417196
  +Save
• Supplementary figure S2 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417196.v1
  +Save
• Supplementary figure S1 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417199
  +Save
• Supplementary figure S1 from CD4+ T-cell–Mediated Rejection of MHC Class II–Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
  2023 DOI: 10.1158/0008-5472.22417199.v1
  +Save